Project Grant R01AG096517
- Federal Grant Award Summary The University of Michigan received a $2.99 million Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), effective September 1, 2025 through August 31, 2029. This research project investigates reactive oxygen species (ROS) as early-life modulators of longevity and examines the molecular mechanisms underlying aging and age-related diseases, including Alzheimer's and Parkinson's disease. The research leverages findings...
- Federal Grant Award Summary Michigan State University's Henry Ford Health+Michigan State University Health Sciences partnership received a $2.86 million Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), awarded on August 15, 2025, with a completion date of July 31, 2029. This research project aims to model the effects of cadmium exposure on Alzheimer's disease (AD) pathology and neurodegeneration through a multi-principal investigator approach...
- Grant Award Summary The University of Michigan, through its Office of Research and Sponsored Projects, received a $2.9M Project Grant from the National Institute on Aging (CFDA 93.866 - Aging Research) awarded August 1, 2025, with completion targeted for April 30, 2030. This award supports the development of novel multimodal variational autoencoder (VAE) machine learning models designed to identify latent factors associated with cognitive resilience to Alzheimer's disease (AD) and AD-related...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded the University of Michigan a $303,449 project grant effective June 1, 2025, through May 31, 2027, under the Aging Research program (CFDA 93.866) to investigate the genomic impact of transposable elements (TEs) in Alzheimer's disease and related dementias (ADRD). The research will leverage large-scale genomic datasets and clinical information from major Alzheimer's disease cohorts to overcome analytical challenges...
- Federal Project Grant Award Summary The University of Michigan, through its Office of Research and Sponsored Projects, received a $385,560 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) awarded on June 15, 2025, with completion expected by March 31, 2030. The research project addresses the role of Alzheimer's Disease (AD) pathology in Mild Behavioral Impairment (MBI) by investigating network-level neurobiological mechanisms underlying...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded the Regents of the University of Michigan a Project Grant totaling $284,108 under the Aging Research program (CFDA 93.866), with an award period from January 1, 2026, through December 31, 2027. This research initiative delivers scientific investigation into how mechanical changes in the aging brain—specifically decreased stiffness and increased viscoelasticity—influence microglial function and contribute to...
- Federal Grant Award Summary The University of Minnesota's Regents, through its Office of Sponsored Projects Administration, received a $1.29M Project Grant from the National Institute on Aging (Aging Research program, CFDA 93.866) awarded February 1, 2026, with completion targeted for December 31, 2030. This research initiative will create a novel epidemiological data resource by linking 15,792 participants from the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS) to their...
- Federal Project Grant Award Summary The University of Michigan received a $424,371 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded February 15, 2026, with completion targeted for February 14, 2028. The research project investigates how hormone contraceptive (HC) exposure across the female lifespan protects against Alzheimer's disease (AD) progression, with emphasis on estrogen's cumulative effects and progestin-mediated...
- Federal Grant Award Summary Michigan State University received a $369,654 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective May 15, 2025 through February 28, 2030. This research initiative examines cultural variation in how spousal depressive symptoms impact Alzheimer's disease (AD) prevalence and physical health outcomes across the second half of life. The project leverages longitudinal panel data from the International Sister...
- Federal Grant Award Summary The University of Michigan, through its Office of Research and Sponsored Projects, received a $1.73 million Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded March 1, 2026, with completion expected January 31, 2031. This award supports comprehensive research utilizing heterogeneous mouse models—specifically the Diversity Outbred (DO) panel—to identify genetic determinants and mechanisms underlying...
The University of Michigan received a $1.7 million Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) awarded on April 1, 2026, with a completion date of January 31, 2031. This research initiative addresses the national priority of understanding modifiable causes of Alzheimer's disease and related dementias (ADRD) by leveraging biospecimens from the Health and Retirement Study, one of the largest longitudinal U.S. population-based cohorts. The primary deliverables include generating a publicly available prospective environmental chemical resource with exposure measures—including pesticides and per- and polyfluoroalkyl substances (PFAS)—collected years before ADRD onset or cognitive impairment in a cohort of participants aged 50 and older. The research involves two primary aims: first, performing state-of-the-art non-targeted analysis to measure chemical levels in serum and test for associations with cognitive function, cognitive decline, ADRD biomarker levels, and ADRD incidence; and second, integrating mixtures of chemical and social exposures into a comprehensive "exposome" framework to examine complex environmental contributors to ADRD across diverse geographic locations and socioeconomic status groups. The project will utilize existing biannual cognitive measures and ADRD fluid biomarker data from HRS participants to establish prospective temporal relationships between environmental exposures and disease outcomes, generating evidence-based data to inform ADRD prevention strategies.Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.7m | 3/25/26 |